Tag - Myomo

Myomo Announces Technology Licensing Program for International Markets

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, today announced that it has launched a business development program to bring its proprietary MyoPro orthotic product line to a greater number of country markets outside of the United States. Read more >>

Myomo®’s International Distribution Partners Launch Patient Screening Days

Myomo, Inc., a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper limb paralysis, announces that its international distributors in six countries are adopting the marketing model used successfully in the U.S. of introducing the MyoPro® powered orthosis to candidates through screening days. Read more >>

Myomo closes $6m funding round

Myomo said today that it closed a $6.4 million round of financing.

The Cambridge, Mass.-based wearable medical robotics company said that it floated approximately four million shares of its common stock at $1.40 per share for gross proceeds of approximately $5.5 million. Read more >>

Myomo Announces CFO Succession

Myomo Inc., a wearable medical robotics company that offers expanded mobility for those suffering from neurological disorders and upper limb paralysis, today announced that Ralph A. Goldwasser, its Chief Financial Officer, is retiring effective as of February 18, 2019. Read more >>

Myomo® to Present at Noble Capital Markets’ 15th Annual Investor Conference

Myomo, Inc., a wearable medical robotics company, today announced that it will be presenting at NobleCon15 – Noble Capital Markets’ Fifteenth Annual Investor Conference at the W Hotel, Fort Lauderdale, Florida on Monday, January 28th at 10:30 AM EST – Studio 3. Chairman and Chief Executive Officer Paul R. Gudonis and Chief Financial Officer Ralph A. Goldwasser will be presenting, as well as meeting with investors. Read more >>